Challenges in Psychiatric Oncology: Cancer-Related Cognitive Impairment and Use of Psychostimulants

Simple item page
dc.contributor.authorO'Brien, Virginia C.en
dc.date.accessioned2022-02-09T20:49:46Zen
dc.date.available2022-02-09T20:49:46Zen
dc.date.issued2019-09-24en
dc.date.updated2022-02-09T20:49:46Zen
dc.description.abstractCancer-related cognitive impairment (CRCI) is a common side effect of cancer and its treatment that can significantly impact patients' quality of life. CRCI may arise before, during or after cancer treatment, but for up to 30% of patients, CRCI persists1. The etiology of CRCI is hypothesized to be due to direct cytotoxic effects, oxidative stress, and/or the body's immune response to cancer and its treatment. This lack of certainty surrounding the cause of CRCI makes identification of appropriate interventions challenging. Persistent CRCI can significantly impact patients' role functioning, thus treating the symptoms of CRCI is paramount to comprehensive cancer care.en
dc.description.versionAccepted versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.urihttp://hdl.handle.net/10919/108240en
dc.language.isoenen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.titleChallenges in Psychiatric Oncology: Cancer-Related Cognitive Impairment and Use of Psychostimulantsen
dc.typePosteren
dc.type.dcmitypeTexten
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Psychiatry and Behavioral Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Psychiatry and Behavioral Medicine/Psychiatry and Behavioral Medicineen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IPOS.Poster.2019.pdf
Size:
120.85 KB
Format:
Adobe Portable Document Format
Download

Collections

All Faculty Deposits
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)